Munish Kumar Kannabhiran, MD
Cardiovascular Disease · Richland, WANPI 1073912655
Payments from drug & device makers
What this record shows
This record is dominated by grants: $76,947 of the $84,784 with a category attached, or 90.8%. 12 manufacturers reported payments, led by Abbott at 51.6% of the total. Reporting peaked in 2021 at $76,728 and has fallen 96.7% since, to $2,520 in 2025. Among cardiovascular disease clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $390.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$44K
- Biosense Webster, Inc.$26K
- Boston Scientific$8K
- Medtronic$5K
- Biotronik Inc.$2K
- Pfizer$35
- plus $159 from 6 others
What the payments were for
- Grants$76,94791%
- Travel & lodging$2,7413%
- Food & beverage$4,8616%
- Education$2340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 27 | $43,786 |
| Biosense Webster, Inc. | 23 | $25,887 |
| Boston Scientific | 31 | $8,211 |
| Medtronic(2 entities) | 117 | $4,886 |
| Biotronik Inc. | 9 | $1,820 |
| Pfizer | 2 | $35 |
| Amgen | 2 | $33 |
| Cardiva Medical, Inc. | 1 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 2 | $27 |
| Atricure, Inc. | 1 | $27 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASSURITY$21,617
- TACTICATH$21,617
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$7,500
- Micra$1,330
- Carto 3$266
- AFFERA MAPPING SYSTEM$173
- WATCHMAN Access System$140
- OCTARAY MAPPING CATHETER$139
- QDOT MICRO Catheter$118
- PulseSelect$103
How this compares
$84,784 in reported general payments places this provider in the 95th percentile of 370 cardiovascular disease providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 53 | $890 |
| Amiodarone Hcl | 22 | $743 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Richland
- Nagarjuna Reddy GujjulaRichland$14K
- Robert BersinBellevue$657K
- Mariko HarperSeattle$246K
- Gary OppenheimSeattle$153K
- Kelley BranchSeattle$103K
- Erik WissnerSeattle$67K
- Younghoon KwonSeattle$66K
- Thomas AmidonBellevue$64K
- Aron BenderSeattle$60K
- Vidhushei YogeswaranSeattle$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.